US FDA approves Novartis Kymriah CAR-T cell therapy for adult patients with relapsed or refractory…
68 per cent of patients receiving Kymriah in the Elara trial experienced complete response, with an 86 per cent overall response…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.